Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Joint Corp (JYNT)
NASDAQ:JYNT
Holding JYNT?
Track your performance easily
Earnings Data
Report Date
Mar 06, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
$0.01Last Year’s EPS
-$0.75Same Quarter Last Year
Moderate Buy
Based on 4 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 07, 2024
|% Change Since: -13.55%
|Next Earnings Date:Mar 06, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mix of achievements and challenges. While there were strong performances in system-wide sales and strategic initiatives like refranchising and digital improvements, these were countered by financial setbacks such as decreased net income and revised growth projections due to consumer headwinds.Company Guidance
During the Q3 2024 earnings call for The Joint Corp., several key metrics and strategic plans were discussed. The company reported system-wide sales of $129.3 million, up 8% year-over-year, and a total clinic count of 963 as of September 30, 2024. The system-wide comp sales for clinics open at least 13 months increased by 4%. Despite these gains, the company adjusted its 2024 guidance, anticipating system-wide sales between $525 million and $535 million, reflecting ongoing consumer headwinds. New franchise clinic openings are expected to be between 55 and 60, a decrease from the previous year due to refranchising efforts. Adjusted EBITDA for Q3 2024 was $2.4 million, with franchise clinic adjusted EBITDA increasing by 9% to $5.8 million. Refranchising remains a focus, with a portfolio mix now 87% franchised, as the company aims to reinvest capital raised from these efforts. CEO Sanjiv Razdan emphasized initiatives to strengthen clinic economics, enhance patient care, and drive innovation.System-Wide Sales Growth
System-wide sales increased to $129.3 million, up 8% from the previous year.
Refranchising Strategy Progress
The company refranchised 1 clinic and saw broad interest in their corporate clinics, with ongoing transactions for 9 clinics in Savannah and Kansas City.
Increased Digital Lead Conversion
New patient digital lead conversion increased from 46% in July to 49% in September.
Launch of Initial Visit Bookings Platform
The platform has been rolled out to 500 clinics, resulting in strong qualitative and quantitative feedback from new patients.
25th Anniversary Celebration and Franchise Recognition
The Joint chiropractic network celebrated its 25th anniversary and was recognized in Franchise Tank's Top 400 list, moving up 18 spots to Position 150.
---
JYNT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
JYNT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 07, 2024 | $11.88 | $11.61 | -2.27% |
| Aug 08, 2024 | $12.33 | $11.30 | -8.35% |
| May 02, 2024 | $12.86 | $16.12 | +25.35% |
| Mar 07, 2024 | $9.14 | $11.88 | +29.98% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Joint Corp (JYNT) report earnings?
Joint Corp (JYNT) is schdueled to report earning on Mar 06, 2025, TBA Not Confirmed.
What is Joint Corp (JYNT) earnings time?
Joint Corp (JYNT) earnings time is at Mar 06, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is JYNT EPS forecast?
JYNT EPS forecast for the fiscal quarter 2024 (Q4) is $0.01.
---